$HYEX

HEALTHY EXTRACTS INC.

CIK:0001630176|SEC Filings

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
REVENUE
Revenue	$ 2,067,212	$ 968,656	$ 3,677,956	$ 1,899,935
Net revenue	2,067,212	968,656	3,677,956	1,899,935
COST OF REVENUE
Cost of goods sold	614,768	375,828	1,236,811	882,123
Total cost of revenue	614,768	375,828	1,236,811	882,123
GROSS PROFIT	1,452,444	592,827	2,441,145	1,017,812
OPERATING EXPENSES
General and administrative	1,501,206	698,434	2,818,116	1,232,267
Total operating expenses	1,501,206	698,434	2,818,116	1,232,267
OTHER INCOME (EXPENSE)
Interest expense, net of interest income	(106,632)	(29,259)	(191,538)	(63,817)
Change in fair value on derivative	21,039	201,986	304,058	(53,468)
Gain/loss of foreign transactions	4,966	0	4,966	0
Gain/loss of disposal of assets	0	0	(70,000)	0
Total other income (expense)	(80,626)	172,727	47,486	(117,285)
Net income/(loss) before income tax provision	(129,389)	67,120	(329,486)	(331,739)
NET INCOME/(LOSS)	$ (129,389)	$ 67,120	$ (329,486)	$ (331,739)
Income/(Loss) per share - basic and diluted	$ (0.01)	$ 0.02	$ (0.02)	$ (0.11)
Weighted average number of shares outstanding - basic and diluted	16,344,029	3,050,879	15,536,102	3,050,879

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended		138 Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026
Cash Flows from Operating Activities
Net Income/(Loss)	$ (129,389)	$ 67,120	$ (329,486)	$ (331,739)	$ (329,486)	$ (331,739)	$ 20,450,948
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities
Depreciation and amortization			348,093	695
Common stock issued for services			55,824	34,169
Gain/loss of disposal of assets	0	0	70,000	0
Discount expensed from note payable and notes payable			35,734
Discount expensed from note payable and notes payable- related party			21,583
Interest expense			68,438	4,999
Warrants issued for services			225,389	95,152
Change in fair value on derivative liability	(21,039)	(201,986)	(304,058)	53,468
Changes in operating assets and liabilities
Accounts receivable			(203,463)	7,024
Deposit			(8,027)	0
Inventory			344,425	254,337
Note receivable			0	(100,000)
Right of use asset, net - current			221	0
Other current asset			(89,102)	0
Accounts payable			58,263	62,641
Accrued liabilities			118,148	(24,613)
Accrued interest payable			0	7,072
Accrued interest payable - related party			0	13,240
Lease liability - current			0	0
Lease liability - long-term			0	793
Net Cash provided by Operating Activities			411,983	77,236
Cash Flows from Investing Activities
Fixed assets purchase			0	(19,302)
Adli Gummies Inc acquisition			95,971	0
Cash flows (used in) provided by Investing Activities			95,971	(19,302)
Cash Flows from Financing Activities
Payments for repayment of convertible debt			(106,000)	(83,437)
Proceeds from issuance of noted payable			316,000	160,000
Payments for repayment of notes payable			(245,076)	(8,498)
Proceeds from issuance of noted payable - related party			100,000	0
Payments for repayment of noted payable - related party			(37,855)	(37,524)
Payments for repayment of line of credit			492,000	0
Interest payment of notes payable			0	0
Interest payment of notes payable - related party			0	0
Net Cash provided by (used in) Financing Activities			(464,931)	30,540
Increase in cash			43,023	88,474
Cash at beginning of period			146,935	112,020	200,494
Cash at end of period	$ 189,958	$ 200,494	$ 189,958	$ 200,494	$ 189,958	$ 200,494	$ 189,958

CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS
Cash	$ 189,958	$ 146,935
Accounts receivable	607,018	187,750
Inventory, net	644,114	843,357
Deposit	0	0
Offering costs	149,274	149,274
Other current assets	89,102	0
Total current assets	1,679,466	1,327,317
Fixed assets	3,884,990	4,233,083
Deposit	37,794	99,767
Goodwill	26,056,515	21,123,922
Patents/Trademarks	526,647	526,647
Right of use asset, net - non-current	423,438	513,929
Total other assets	30,929,383	26,497,347
TOTAL ASSETS	32,608,849	27,824,664
LIABILITIES
Accounts payable	340,515	108,496
Accrued interest payable	5,388	5,118
Accrued interest payable - related party	116,113	76,401
Accrued liabilities	592,602	613,645
Lease liabilities - current	196,815	171,930
Notes payable - current	927,824	0
Notes payable - related party - current	6,209,827	676,250
Convertible debt, net of discount - current	0	111,330
Total current liabilities	8,389,085	1,763,169
Lease liabilities - long-term	229,110	344,265
Notes payable	1,374,584	1,171,670
Notes payable - related party - non-current	125,276	156,835
Convertible debt, net of discount - non-current	6,750	6,750
Derivative liabilities	48,353	352,411
Total non-current liabilities	1,784,073	2,031,930
Total current and total liabilities	10,173,158	3,795,099
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 75,000,000 shares authorized, no shares issued and outstanding, respectively	0	0
Common stock, $0.001 par value, 50,000,000 shares authorized, 14,741,348 shares issued and outstanding as of June 30, 2026, and 16,870,868 shares issued and outstanding as of December 31, 2025	368,443	368,413
Additional paid-in capital	46,410,732	43,788,013
Treasury stock, at cost, 2,163,686 shares, respectively	(3,892,536)	(5,400)
Accumulated deficit	(20,450,948)	(20,121,462)
Total stockholders' equity	22,435,692	24,029,564
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 32,608,849	$ 27,824,664